Stroke is the leading cause of long-term disability and preventable disability in the United States. It is also the fifth leading cause of death, killing nearly 130,000 people in the U.S. each year.

PHOENIX, AZ—IV tirofiban lessens early neurological deterioration when given within 24 hours of symptom onset in patients with an acute noncardioembolic ischemic stroke who aren’t treated with IV ...

The US Food and Drug Administration (FDA) has approved the thrombolytic tenecteplase (TNKase, Genentech) for treatment of acute ischemic stroke in adults. The drug is administered as a single, ...

Intravenous alteplase is beneficial for patients who present with an acute ischemic stroke and salvageable brain tissue on imaging—with or without a large-vessel occlusion (LVO)—up to 24 hours after ...

When someone’s brought into the emergency room for acute ischemic stroke – or a blocked artery to the brain – a neurologist is called in to determine treatment. But back in 2010, Baylor Healthcare ...

Treatment delays were significantly longer for adult patients with intracerebral hemorrhage (ICH) than for those with acute ischemic stroke (AIS), new research showed. Additionally, initiating ...